Clinical Trial Update: Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC [NA]

View source ↗

Summary

The document updates a safety and efficacy study of lenvatinib combined with VIC-1911 for advanced hepatocellular carcinoma. The trial is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)
• VIC-1911

Snippet

Sponsor: RenJi Hospital | Conditions: Hepatocellular Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING